Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marc Jean Lallemant, M.D.

Title
Institution
Department
Address

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01HD056953 (LALLEMANT, MARC J) Aug 10, 2007 - May 31, 2014
    NIH/NICHD
    Lopinavir/ritonavir + zidovudine to prevent perinatal HIV in Thailand
    Role: Principal Investigator
  2. U01AI069429 (JOURDAIN, GONZAGUE JOSEPH) May 1, 2007 - Jan 31, 2014
    NIH/NIAID
    Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand
    Role: Co-Principal Investigator
  3. R01HD052461 (LALLEMANT, MARC J) Sep 29, 2006 - Jul 31, 2014
    NIH/NICHD
    Standard zidovudine plus infant nevirapine to prevent perinatal HIV in Thailand
    Role: Principal Investigator
  4. R01HD042964 (LALLEMANT, MARC J) Sep 9, 2003 - Jul 31, 2010
    NIH/NICHD
    Monitoring HAART in HIV-infected parents in Thailand
    Role: Principal Investigator
  5. R01HD039615 (LALLEMANT, MARC J) Sep 22, 2000 - Jun 30, 2005
    NIH/NICHD
    NEVIRAPINE+ZIDOVUDINE--PREVENT PERINATAL HIV IN THAILAND
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Rabie H, Denti P, Lee J, Masango M, Coovadia A, Pillay S, Liberty A, Simon F, McIlleron H, Cotton MF, Lallemant M. Lopinavir-ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir-ritonavir without rifampicin: a pharmacokinetic modelling and clinical study. Lancet HIV. 2018 Dec 06. PMID: 30529029.
    Citations:    Fields:    
  2. Ford D, Turner R, Turkova A, Penazzato M, Musiime V, Bwakura-Dangarembizi M, Violari A, Chabala C, Puthanakit T, Sudjaritruk T, Cressey TR, Lallemant M, Gibb DM. Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV. J Acquir Immune Defic Syndr. 2018 Aug 15; 78 Suppl 1:S40-S48. PMID: 29994919.
    Citations: 1     Fields:    
  3. Traisathit P, Delory T, Ngo-Giang-Huong N, Somsamai R, Techakunakorn P, Theansavettrakul S, Kanjanavanit S, Mekmullica J, Ngampiyaskul C, Na-Rajsima S, Lallemant M, Cressey TR, Jourdain G, Collins IJ, Le Coeur S. Brief Report: AIDS-Defining Events and Deaths in HIV-Infected Children and Adolescents on Antiretrovirals: A 14-Year Study in Thailand. J Acquir Immune Defic Syndr. 2018 01 01; 77(1):17-22. PMID: 29040162.
    Citations: 2     Fields:    Translation:Humans
  4. Balasubramanian R, Fowler MG, Dominguez K, Lockman S, Tookey PA, Huong NNG, Nesheim S, Hughes MD, Lallemant M, Tosswill J, Shaffer N, Sherman G, Palumbo P, Shapiro DE. Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1. AIDS. 2017 11 28; 31(18):2465-2474. PMID: 28926397.
    Citations:    Fields:    Translation:HumansCells
  5. Cressey TR, Punyawudho B, Le Coeur S, Jourdain G, Saenjum C, Capparelli EV, Jittayanun K, Phanomcheong S, Luvira A, Borkird T, Puangsombat A, Aarons L, Sukrakanchana PO, Urien S, Lallemant M. Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):554-560. PMID: 28489732.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  6. Penazzato M, Gnanashanmugam D, Rojo P, Lallemant M, Lewis LL, Rocchi F, Saint Raymond A, Ford N, Hazra R, Giaquinto C, Belew Y, Gibb DM, Abrams EJ. Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations. Clin Infect Dis. 2017 Jun 01; 64(11):1597-1603. PMID: 29190337.
    Citations: 4     Fields:    Translation:Humans
  7. Salvadori N, Ngo-Giang-Huong N, Duclercq C, Kanjanavanit S, Ngampiyaskul C, Techakunakorn P, Puangsombat A, Figoni J, Mary JY, Collins IJ, Cressey TR, Le Cœur S, Sirirungsi W, Lallemant M, McIntosh K, Jourdain G. Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral Therapy. J Pediatric Infect Dis Soc. 2017 Jun 01; 6(2):161-167. PMID: 28204517.
    Citations: 1     Fields:    Translation:Humans
  8. Nebot Giralt A, Nöstlinger C, Lee J, Salami O, Lallemant M, Ouma O, Nyamongo I, Marchal B. Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation. BMJ Open. 2017 03 29; 7(3):e014528. PMID: 28360249.
    Citations: 2     Fields:    Translation:Humans
  9. Rabie H, Decloedt EH, Garcia-Prats AJ, Cotton MF, Frigati L, Lallemant M, Hesseling A, Schaaf HS. Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis. Expert Opin Pharmacother. 2017 Apr; 18(6):589-598. PMID: 28346018.
    Citations:    Fields:    Translation:Humans
  10. Delory T, Ngo-Giang-Huong N, Rangdaeng S, Chotivanich N, Limtrakul A, Putiyanun C, Suriyachai P, Matanasarawut W, Jarupanich T, Liampongsabuddhi P, Heard I, Jourdain G, Lallemant M, Le Coeur S. Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand. J Infect. 2017 05; 74(5):501-511. PMID: 28254419.
    Citations: 1     Fields:    Translation:HumansCells
  11. Ngo-Giang-Huong N, Wittkop L, Judd A, Reiss P, Goetghebuer T, Duiculescu D, Noguera-Julian A, Marczynska M, Giacquinto C, Ene L, Ramos JT, Cellerai C, Klimkait T, Brichard B, Valerius N, Sabin C, Teira R, Obel N, Stephan C, de Wit S, Thorne C, Gibb D, Schwimmer C, Campbell MA, Pillay D, Lallemant M. Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project. BMC Infect Dis. 2016 11 08; 16(1):654. PMID: 27825316.
    Citations: 1     Fields:    Translation:HumansCells
  12. Bouazza N, Cressey TR, Foissac F, Bienczak A, Denti P, McIlleron H, Burger D, Penazzato M, Lallemant M, Capparelli EV, Treluyer JM, Urien S. Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients. J Antimicrob Chemother. 2017 02; 72(2):490-495. PMID: 27798221.
    Citations: 3     Fields:    Translation:Humans
  13. Kekitiinwa A, Musiime V, Thomason MJ, Mirembe G, Lallemant M, Nakalanzi S, Baptiste D, Walker AS, Gibb DM, Judd A. Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children. Antivir Ther. 2016; 21(7):579-585. PMID: 27128199.
    Citations: 4     Fields:    Translation:Humans
  14. Lee JSF, Sagaon Teyssier L, Dongmo Nguimfack B, Collins IJ, Lallemant M, Perriens J, Moatti JP. An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012. BMC Pediatr. 2016 Mar 15; 16:41. PMID: 26979974.
    Citations: 2     Fields:    Translation:Humans
  15. Penazzato M, Lee J, Capparelli E, Essajee S, Ford N, Ojoo A, Pascual F, Sugandhi N, Lallemant M. Optimizing drugs to reach treatment targets for children and adolescents living with HIV. J Int AIDS Soc. 2015; 18(Suppl 6):20270. PMID: 26639117.
    Citations: 8     Fields:    Translation:Humans
  16. Lallemant M, Le Coeur S, Sirirungsi W, Cressey TR, Ngo-Giang-Huong N, Traisathit P, Klinbuayaem V, Sabsanong P, Kanjanavikai P, Jourdain G, Mcintosh K, Koetsawang S. Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand. AIDS. 2015 Nov 28; 29(18):2497-507. PMID: 26372485.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  17. Homkham N, Cressey TR, Bouazza N, Chanta C, Aurpibul L, Narkbunnam T, Krikajornkitti S, Kamonpakorn N, Lallemant M, Ingsrisawang L, Salvadori N, Treluyer JM, Urien S, Jourdain G. Efavirenz Concentrations and Probability of HIV Replication in Children. Pediatr Infect Dis J. 2015 Nov; 34(11):1214-7. PMID: 26226442.
    Citations: 1     Fields:    Translation:HumansCells
  18. Sripan P, Le Coeur S, Ingsrisawang L, Cressey TR, Bouazza N, Foissac F, Ngo-Giang-Huong N, Traisathit P, Srirompotong U, Ayudhaya OP, Puangsombat A, Jungpipun J, Jittayanun K, Tréluyer JM, Jourdain G, Lallemant M, Urien S. Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy. Antivir Ther. 2016; 21(5):435-40. PMID: 26492107.
    Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
  19. Sripan P, Le Coeur S, Amzal B, Ingsrisawang L, Traisathit P, Ngo-Giang-Huong N, McIntosh K, Cressey TR, Sangsawang S, Rawangban B, Kanjanavikai P, Tréluyer JM, Jourdain G, Lallemant M, Urien S. Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One. 2015; 10(8):e0137368. PMID: 26317220.
    Citations:    Fields:    
  20. Riyaten P, Salvadori N, Traisathit P, Ngo-Giang-Huong N, Cressey TR, Leenasirimakul P, Techapornroong M, Bowonwatanuwong C, Kantipong P, Nilmanat A, Yutthakasemsunt N, Chutanunta A, Thongpaen S, Klinbuayaem V, Decker L, Le Cœur S, Lallemant M, Capeau J, Mary JY, Jourdain G. New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in Thailand. J Acquir Immune Defic Syndr. 2015 Aug 01; 69(4):453-9. PMID: 25886928.
    Citations: 6     Fields:    Translation:Humans
  21. Sripan P, Le Coeur S, Amzal B, Ingsrisawang L, Traisathit P, Ngo-Giang-Huong N, McIntosh K, Cressey TR, Sangsawang S, Rawangban B, Kanjanavikai P, Tréluyer JM, Jourdain G, Lallemant M, Urien S. Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One. 2015; 10(6):e0130917. PMID: 26114293.
    Citations:    Fields:    
  22. Sripan P, Le Coeur S, Amzal B, Ingsrisawang L, Traisathit P, Ngo-Giang-Huong N, McIntosh K, Cressey TR, Sangsawang S, Rawangban B, Kanjanavikai P, Tréluyer JM, Jourdain G, Lallemant M, Urien S. Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One. 2015; 10(5):e0126647. PMID: 25992639.
    Citations: 4     Fields:    Translation:Humans
  23. Suaysod R, Ngo-Giang-Huong N, Salvadori N, Cressey TR, Kanjanavanit S, Techakunakorn P, Krikajornkitti S, Srirojana S, Laomanit L, Chalermpantmetagul S, Lallemant M, Le Cœur S, McIntosh K, Traisathit P, Jourdain G. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy. Clin Infect Dis. 2015 Jul 01; 61(1):95-101. PMID: 25838288.
    Citations: 4     Fields:    Translation:HumansCells
  24. Sirirungsi W, Urien S, Harrison L, Kamkon J, Tawon Y, Luekamlung N, Thongpaen S, Nilmanat A, Jourdain G, Lallemant M, Le Coeur S, Ngo-Giang-Huong N, Owen A, Cressey TR. No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adults. J Acquir Immune Defic Syndr. 2015 Apr 01; 68(4):e56-9. PMID: 25559596.
    Citations: 2     Fields:    Translation:Humans
  25. Celletti F, Cohen J, Connor C, Lallemant M, Lee JS. How can we end paediatric AIDS? Lancet HIV. 2015 Mar; 2(3):e80-1. PMID: 26424548.
    Citations:    Fields:    Translation:Humans
  26. Bouazza N, Foissac F, Fauchet F, Burger D, Kiechel JR, Treluyer JM, Capparelli EV, Lallemant M, Urien S. Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinations. Antivir Ther. 2015; 20(2):225-33. PMID: 25279808.
    Citations: 5     Fields:    Translation:HumansCells
  27. Cressey TR, Urien S, Capparelli EV, Best BM, Buranabanjasatean S, Limtrakul A, Rawangban B, Sabsanong P, Treluyer JM, Jourdain G, Stek A, Lallemant M, Mirochnick M. Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy. J Antimicrob Chemother. 2015 Jan; 70(1):217-24. PMID: 25261418.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  28. Musiime V, Fillekes Q, Kekitiinwa A, Kendall L, Keishanyu R, Namuddu R, Young N, Opilo W, Lallemant M, Walker AS, Burger D, Gibb DM. The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children. J Acquir Immune Defic Syndr. 2014 Jun 01; 66(2):148-54. PMID: 24828266.
    Citations: 16     Fields:    Translation:Humans
  29. Chaillon A, Samleerat T, Zoveda F, Ballesteros S, Moreau A, Ngo-Giang-Huong N, Jourdain G, Gianella S, Lallemant M, Depaulis F, Barin F. Estimating the timing of mother-to-child transmission of the human immunodeficiency virus type 1 using a viral molecular evolution model. PLoS One. 2014; 9(4):e90421. PMID: 24717647.
    Citations: 5     Fields:    Translation:HumansCells
  30. Collins IJ, Cairns J, Ngo-Giang-Huong N, Sirirungsi W, Leechanachai P, Le Coeur S, Samleerat T, Kamonpakorn N, Mekmullica J, Jourdain G, Lallemant M. Cost-effectiveness of early infant HIV diagnosis of HIV-exposed infants and immediate antiretroviral therapy in HIV-infected children under 24 months in Thailand. PLoS One. 2014; 9(3):e91004. PMID: 24632750.
    Citations: 5     Fields:    Translation:Humans
  31. Collins I, Cairns J, Le Coeur S, Pagdi K, Ngampiyaskul C, Layangool P, Borkird T, Na-Rajsima S, Wanchaitanawong V, Jourdain G, Lallemant M. Five-year trends in antiretroviral usage and drug costs in HIV-infected children in Thailand. J Acquir Immune Defic Syndr. 2013 Sep 01; 64(1):95-102. PMID: 23945253.
    Citations: 6     Fields:    Translation:Humans
  32. Jourdain G, Le Cœur S, Ngo-Giang-Huong N, Traisathit P, Cressey TR, Fregonese F, Leurent B, Collins IJ, Techapornroong M, Banchongkit S, Buranabanjasatean S, Halue G, Nilmanat A, Luekamlung N, Klinbuayaem V, Chutanunta A, Kantipong P, Bowonwatanuwong C, Lertkoonalak R, Leenasirimakul P, Tansuphasawasdikul S, Sang-A-Gad P, Pathipvanich P, Thongbuaban S, Wittayapraparat P, Eiamsirikit N, Buranawanitchakorn Y, Yutthakasemsunt N, Winiyakul N, Decker L, Barbier S, Koetsawang S, Sirirungsi W, McIntosh K, Thanprasertsuk S, Lallemant M. Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand. PLoS Med. 2013 Aug; 10(8):e1001494. PMID: 23940461.
    Citations: 13     Fields:    Translation:Humans
  33. Khamduang W, Gaudy-Graffin C, Ngo-Giang-Huong N, Jourdain G, Moreau A, Borkird T, Layangool P, Kamonpakorn N, Jitphiankha W, Kwanchaipanich R, Potchalongsin S, Lallemant M, Sirirungsi W, Goudeau A. Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring. J Clin Virol. 2013 Oct; 58(2):415-21. PMID: 23916828.
    Citations: 3     Fields:    Translation:HumansCells
  34. Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW. Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. J Infect Dis. 2013 Jun 15; 207 Suppl 2:S70-7. PMID: 23687292.
    Citations: 15     Fields:    Translation:HumansCells
  35. Khamduang W, Ngo-Giang-Huong N, Gaudy-Graffin C, Jourdain G, Suwankornsakul W, Jarupanich T, Chalermpolprapa V, Nanta S, Puarattana-Aroonkorn N, Tonmat S, Lallemant M, Goudeau A, Sirirungsi W. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clin Infect Dis. 2013 Jun; 56(12):1704-12. PMID: 23487379.
    Citations: 13     Fields:    Translation:HumansCells
  36. Harrison L, Ananworanich J, Hamadache D, Compagnucci A, Penazzato M, Bunupuradah T, Mazza A, Ramos JT, Flynn J, Rampon O, Mellado Pena MJ, Floret D, Marczynska M, Puga A, Forcat S, Riault Y, Lallemant M, Castro H, Gibb DM, Giaquinto C. Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children. AIDS Behav. 2013 Jan; 17(1):193-202. PMID: 22584916.
    Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
  37. Collins IJ, Cairns J, Jourdain G, Fregonese F, Nantarukchaikul M, Lertpienthum N, Wannarit P, Attavinijtrakarn P, Layangool P, Le Coeur S, Lallemant M. Hospitalization trends, costs, and risk factors in HIV-infected children on antiretroviral therapy. AIDS. 2012 Sep 24; 26(15):1943-52. PMID: 22824633.
    Citations: 4     Fields:    Translation:HumansCells
  38. Duong T, Jourdain G, Ngo-Giang-Huong N, Le Cœur S, Kantipong P, Buranabanjasatean S, Leenasirimakul P, Ariyadej S, Tansuphasawasdikul S, Thongpaen S, Lallemant M. Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in Thailand. PLoS One. 2012; 7(8):e43375. PMID: 22905264.
    Citations: 6     Fields:    Translation:HumansCells
  39. Khamduang W, Gaudy-Graffin C, Ngo-Giang-Huong N, Jourdain G, Moreau A, Luekamlung N, Halue G, Buranawanitchakorn Y, Kunkongkapan S, Buranabanjasatean S, Lallemant M, Sirirungsi W, Goudeau A. Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand. PLoS One. 2012; 7(7):e42184. PMID: 22860080.
    Citations: 4     Fields:    Translation:HumansCells
  40. Fregonese F, Collins IJ, Jourdain G, Lecoeur S, Cressey TR, Ngo-Giang-Houng N, Banchongkit S, Chutanunta A, Techapornroong M, Lallemant M. Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand. J Acquir Immune Defic Syndr. 2012 May 01; 60(1):91-8. PMID: 22293548.
    Citations: 19     Fields:    Translation:Humans
  41. Thenin S, Samleerat T, Tavernier E, Ngo-Giang-Huong N, Jourdain G, Lallemant M, Barin F, Braibant M. Envelope glycoproteins of human immunodeficiency virus type 1 variants issued from mother-infant pairs display a wide spectrum of biological properties. Virology. 2012 Apr 25; 426(1):12-21. PMID: 22310702.
    Citations: 10     Fields:    Translation:HumansCells
  42. Ngo-Giang-Huong N, Jourdain G, Amzal B, Sang-a-gad P, Lertkoonalak R, Eiamsirikit N, Tansuphasawasdikul S, Buranawanitchakorn Y, Yutthakasemsunt N, Mekviwattanawong S, McIntosh K, Lallemant M. Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis. PLoS One. 2011; 6(11):e27427. PMID: 22132100.
    Citations: 7     Fields:    Translation:HumansCells
  43. Khamduang W, Jourdain G, Sirirungsi W, Layangool P, Kanjanavanit S, Krittigamas P, Pagdi K, Somsamai R, Sirinontakan S, Hinjiranandana T, Ardonk W, Hongsiriwon S, Nanta S, Borkird T, Lallemant M, McIntosh K, Ngo-Giang-Huong N. The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers. J Acquir Immune Defic Syndr. 2011 Oct 01; 58(2):188-92. PMID: 21792064.
    Citations: 13     Fields:    Translation:HumansCells
  44. Lallemant M, Chang S, Cohen R, Pecoul B. Pediatric HIV--a neglected disease? N Engl J Med. 2011 Aug 18; 365(7):581-3. PMID: 21848457.
    Citations: 17     Fields:    Translation:Humans
  45. Cressey TR, Urien S, Hirt D, Halue G, Techapornroong M, Bowonwatanuwong C, Leenasirimakul P, Treluyer JM, Jourdain G, Lallemant M. Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected Thai patients receiving indinavir boosted with ritonavir. Ther Drug Monit. 2011 Feb; 33(1):25-31. PMID: 21233689.
    Citations: 4     Fields:    Translation:Humans
  46. Collins IJ, Jourdain G, Hansudewechakul R, Kanjanavanit S, Hongsiriwon S, Ngampiyasakul C, Sriminiphant S, Technakunakorn P, Ngo-Giang-Huong N, Duong T, Le Coeur S, Jaffar S, Lallemant M. Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study. Clin Infect Dis. 2010 Dec 15; 51(12):1449-57. PMID: 21054181.
    Citations: 23     Fields:    Translation:Humans
  47. Lallemant M, Jourdain G. Preventing mother-to-child transmission of HIV—protecting this generation and the next. N Engl J Med. 2010 Oct 14; 363(16):1570-2. PMID: 20942674.
    Citations: 3     Fields:    Translation:Humans
  48. Briand N, Le Coeur S, Jourdain G, Hotrawarikarn S, Sirinontakan S, Hinjiranandana T, Kanjanavanit S, Traisathit P, McIntosh K, Lallemant M. Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand. AIDS Res Hum Retroviruses. 2010 Oct; 26(10):1163-6. PMID: 20854205.
    Citations: 1     Fields:    Translation:HumansCells
  49. Cressey TR, Jourdain G, Rawangban B, Varadisai S, Kongpanichkul R, Sabsanong P, Yuthavisuthi P, Chirayus S, Ngo-Giang-Huong N, Voramongkol N, Pattarakulwanich S, Lallemant M. Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy. AIDS. 2010 Sep 10; 24(14):2193-200. PMID: 20625263.
    Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
  50. Jourdain G, Wagner TA, Ngo-Giang-Huong N, Sirirungsi W, Klinbuayaem V, Fregonese F, Nantasen I, Techapornroong M, Halue G, Nilmanat A, Wittayapraparat P, Chalermpolprapa V, Pathipvanich P, Yuthavisuthi P, Frenkel LM, Lallemant M. Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure. Clin Infect Dis. 2010 May 15; 50(10):1397-404. PMID: 20377404.
    Citations: 16     Fields:    Translation:HumansCells
  51. Lallemant M, Ngo-Giang-Huong N, Jourdain G, Traisaithit P, Cressey TR, Collins IJ, Jarupanich T, Sukhumanant T, Achalapong J, Sabsanong P, Chotivanich N, Winiyakul N, Ariyadej S, Kanjanasing A, Ratanakosol J, Hemvuttiphan J, Kengsakul K, Wannapira W, Sittipiyasakul V, Pornkitprasarn W, Liampongsabuddhi P, McIntosh K, Van Dyke RB, Frenkel LM, Koetsawang S, Le Coeur S, Kanchana S. Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine. Clin Infect Dis. 2010 Mar 15; 50(6):898-908. PMID: 20158398.
    Citations: 10     Fields:    Translation:HumansCells
  52. Wagner TA, Kress CM, Beck I, Techapornroong M, Wittayapraparat P, Tansuphasawasdikul S, Jourdain G, Ngo-Giang-Huong N, Lallemant M, Frenkel LM. Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay. J Clin Microbiol. 2010 May; 48(5):1555-61. PMID: 20181911.
    Citations: 9     Fields:    Translation:HumansCells
  53. Ngo-Giang-Huong N, Jourdain G, Sirirungsi W, Decker L, Khamduang W, Le Coeur S, Sirinontakan S, Somsamai R, Pagdi K, Hemvuttiphan J, McIntosh K, Barin F, Lallemant M. Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand. Int J Infect Dis. 2010 Jul; 14(7):e602-7. PMID: 20047847.
    Citations: 5     Fields:    Translation:HumansCells
  54. Cressey TR, Lallemant M. Pharmacogenomics and the prevention of mother-to-child transmission of HIV. Pharmacogenomics. 2010 Jan; 11(1):1-4. PMID: 20017665.
    Citations:    Fields:    Translation:Humans
  55. Chantarangsu S, Cressey TR, Mahasirimongkol S, Capparelli E, Tawon Y, Ngo-Giang-Huong N, Jourdain G, Lallemant M, Chantratita W. Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women. J Antimicrob Chemother. 2009 Dec; 64(6):1265-73. PMID: 19812066.
    Citations: 17     Fields:    Translation:Humans
  56. Traisathit P, Mary JY, Le Coeur S, Thantanarat S, Jungpichanvanich S, Pornkitprasarn W, Gomutbutra V, Matanasarawut W, Wannapira W, Lallemant M. Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV. J Obstet Gynaecol Res. 2009 Apr; 35(2):225-33. PMID: 19708170.
    Citations: 2     Fields:    Translation:Humans
  57. Cailhol J, Jourdain G, Coeur SL, Traisathit P, Boonrod K, Prommas S, Putiyanun C, Kanjanasing A, Lallemant M. Association of low CD4 cell count and intrauterine growth retardation in Thailand. J Acquir Immune Defic Syndr. 2009 Apr 01; 50(4):409-13. PMID: 19214117.
    Citations: 3     Fields:    Translation:Humans
  58. Samleerat T, Thenin S, Jourdain G, Ngo-Giang-Huong N, Moreau A, Leechanachai P, Ithisuknanth J, Pagdi K, Wannarit P, Sangsawang S, Lallemant M, Barin F, Braibant M. Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission. Virology. 2009 May 10; 387(2):388-94. PMID: 19303619.
    Citations: 16     Fields:    Translation:HumansCells
  59. Pornprasert S, Mary JY, Faye A, Leechanachai P, Limtrakul A, Rugpao S, Sirivatanapa P, Gomuthbutra V, Matanasaravoot W, Le Coeur S, Lallemant M, Barré-Sinoussi F, Menu E, Ngo-Giang-Huong N. Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine. Curr HIV Res. 2009 Mar; 7(2):211-7. PMID: 19275589.
    Citations: 1     Fields:    Translation:HumansCells
  60. Briand N, Pornprasert S, Ngo-Giang-Huong N, Galactéros F, Pissard S, Tatu T, Sanguansermsri T, Jourdain G, Lallemant M, Le Coeur S. Perinatal zidovudine prophylaxis in HIV type-1-infected pregnant women with thalassaemia carriage in Thailand. Antivir Ther. 2009; 14(1):117-22. PMID: 19320245.
    Citations:    Fields:    Translation:HumansCells
  61. Ngo-Giang-Huong N, Khamduang W, Leurent B, Collins I, Nantasen I, Leechanachai P, Sirirungsi W, Limtrakul A, Leusaree T, Comeau AM, Lallemant M, Jourdain G. Early HIV-1 diagnosis using in-house real-time PCR amplification on dried blood spots for infants in remote and resource-limited settings. J Acquir Immune Defic Syndr. 2008 Dec 15; 49(5):465-71. PMID: 18989220.
    Citations: 14     Fields:    Translation:HumansCells
  62. Samleerat T, Braibant M, Jourdain G, Moreau A, Ngo-Giang-Huong N, Leechanachai P, Hemvuttiphan J, Hinjiranandana T, Changchit T, Warachit B, Suraseranivong V, Lallemant M, Barin F. Characteristics of HIV type 1 (HIV-1) glycoprotein 120 env sequences in mother-infant pairs infected with HIV-1 subtype CRF01_AE. J Infect Dis. 2008 Sep 15; 198(6):868-76. PMID: 18700833.
    Citations: 17     Fields:    Translation:HumansCells
  63. Cressey TR, Green H, Khoo S, Treluyer JM, Compagnucci A, Saidi Y, Lallemant M, Gibb DM, Burger DM. Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children. Clin Infect Dis. 2008 May 15; 46(10):1601-8. PMID: 18419497.
    Citations: 6     Fields:    Translation:HumansCells
  64. McIntyre J, Lallemant M. Recent advances in the prevention of mother-to-child transmission. Curr Opin HIV AIDS. 2008 Mar; 3(2):136-8. PMID: 19372955.
    Citations:    Fields:    
  65. McIntyre J, Lallemant M. The prevention of mother-to-child transmission of HIV: are we translating scientific success into programmatic failure? Curr Opin HIV AIDS. 2008 Mar; 3(2):139-45. PMID: 19372956.
    Citations: 4     Fields:    
  66. Jourdain G, Mary JY, Coeur SL, Ngo-Giang-Huong N, Yuthavisuthi P, Limtrakul A, Traisathit P, McIntosh K, Lallemant M. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. J Infect Dis. 2007 Dec 01; 196(11):1629-36. PMID: 18008246.
    Citations: 12     Fields:    Translation:HumansCells
  67. Arvold ND, Ngo-Giang-Huong N, McIntosh K, Suraseranivong V, Warachit B, Piyaworawong S, Changchit T, Lallemant M, Jourdain G. Maternal HIV-1 DNA load and mother-to-child transmission. AIDS Patient Care STDS. 2007 Sep; 21(9):638-43. PMID: 17919090.
    Citations: 12     Fields:    Translation:HumansCells
  68. Cressey TR, Nangola S, Tawon Y, Pattarawarapan M, Lallemant M, Tayapiwatana C. Immunochromatographic strip test for rapid detection of nevirapine in plasma samples from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2007 Sep; 51(9):3361-3. PMID: 17606683.
    Citations: 1     Fields:    Translation:Humans
  69. Chantarangsu S, Cressey T, Mahasirimongkol S, Tawon Y, Ngo-Giang-Huong N, Jourdain G, Lallemant M, Chantratita W. Comparison of the TaqMan and LightCycler systems in evaluation of CYP2B6 516G>T polymorphism. Mol Cell Probes. 2007 Oct-Dec; 21(5-6):408-11. PMID: 17669622.
    Citations: 2     Fields:    Translation:Humans
  70. Briand N, Lallemant M, Jourdain G, Techapalokul S, Tunthanathip P, Suphanich S, Chanpoo T, Traisathit P, McIntosh K, Le Coeur S. Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trial. PLoS Clin Trials. 2007 Apr 27; 2(4):e11. PMID: 17476315.
    Citations: 3     
  71. Cressey TR, Lallemant M. Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update. Infect Genet Evol. 2007 Mar; 7(2):333-42. PMID: 17045554.
    Citations: 15     Fields:    Translation:Humans
  72. Cressey TR, Leenasirimakul P, Jourdain G, Tawon Y, Sukrakanchana PO, Lallemant M. Intensive pharmacokinetics of zidovudine 200 mg twice daily in HIV-1-infected patients weighing less than 60 kg on highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2006 Jul; 42(3):387-9. PMID: 16810125.
    Citations: 6     Fields:    Translation:Humans
  73. Barin F, Jourdain G, Brunet S, Ngo-Giang-Huong N, Weerawatgoompa S, Karnchanamayul W, Ariyadej S, Hansudewechakul R, Achalapong J, Yuthavisuthi P, Ngampiyaskul C, Bhakeecheep S, Hemwutthiphan C, Lallemant M. Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1. J Infect Dis. 2006 Jun 01; 193(11):1504-11. PMID: 16652277.
    Citations: 20     Fields:    Translation:HumansCells
  74. Briand N, Le Coeur S, Traisathit P, Karnchanamayul V, Hansudewechakul R, Ngampiyasakul C, Bhakeecheep S, Ithisukanan J, Hongsiriwon S, McIntosh K, Lallemant M. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission. Pediatr Infect Dis J. 2006 Apr; 25(4):325-32. PMID: 16567984.
    Citations: 10     Fields:    Translation:Humans
  75. Le Coeur S, Halembokaka G, Khlat M, Brouard N, Purhuence F, M'Pelé P, Baty G, Barin F, Lallemant M. Impact of AIDS on adult mortality: a morgue-based study in Pointe-Noire, Republic of Congo. AIDS. 2005 Oct 14; 19(15):1683-7. PMID: 16184039.
    Citations: 4     Fields:    Translation:Humans
  76. Cressey TR, Leenasirimakul P, Jourdain G, Tod M, Sukrakanchana PO, Kunkeaw S, Puttimit C, Lallemant M. Low-doses of indinavir boosted with ritonavir in HIV-infected Thai patients: pharmacokinetics, efficacy and tolerability. J Antimicrob Chemother. 2005 Jun; 55(6):1041-4. PMID: 15883177.
    Citations: 6     Fields:    Translation:Humans
  77. Cressey TR, Jourdain G, Lallemant MJ, Kunkeaw S, Jackson JB, Musoke P, Capparelli E, Mirochnick M. Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr. 2005 Mar 01; 38(3):283-8. PMID: 15735445.
    Citations: 28     Fields:    Translation:HumansCTClinical Trials
  78. Lallemant M, Jourdain G, Le Coeur S, Ngo-Giang-Huong N, Thaineua V. [Prevention of mother-to-child transmission of HIV: a simple and highly efficacious regimen]. Med Sci (Paris). 2005 Jan; 21(1):28-9. PMID: 15639016.
    Citations:    Fields:    Translation:Humans
  79. Jourdain G, Ngo-Giang-Huong N, Le Coeur S, Bowonwatanuwong C, Kantipong P, Leechanachai P, Ariyadej S, Leenasirimakul P, Hammer S, Lallemant M. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med. 2004 Jul 15; 351(3):229-40. PMID: 15247339.
    Citations: 113     Fields:    Translation:HumansCellsCTClinical Trials
  80. Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004 Jul 15; 351(3):217-28. PMID: 15247338.
    Citations: 111     Fields:    Translation:HumansCellsCTClinical Trials
  81. Prasitwattanaseree S, Lallemant M, Costagliola D, Jourdain G, Mary JY. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants. Antivir Ther. 2004 Apr; 9(2):179-85. PMID: 15134179.
    Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
  82. Jiang H, Deeks SG, Kuritzkes DR, Lallemant M, Katzenstein D, Albrecht M, DeGruttola V. Assessing resistance costs of antiretroviral therapies via measures of future drug options. J Infect Dis. 2003 Oct 01; 188(7):1001-8. PMID: 14513420.
    Citations: 8     Fields:    Translation:HumansCells
  83. Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM, Phoolcharoen W, Essex M, McIntosh K, Vithayasai V. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med. 2000 Oct 05; 343(14):982-91. PMID: 11018164.
    Citations: 70     Fields:    Translation:HumansCTClinical Trials
  84. Lallemant M, McIntosh K, Jourdain G, Le Coeur S, Vithayasai V, Lee TH, Hammer S, Prescott N, Essex M. Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World. N Engl J Med. 1998 Mar 19; 338(12):839-40; author reply 840-1. PMID: 9508638.
    Citations: 2     Fields:    Translation:Humans
  85. Litvak E, Siegel JE, Pauker SG, Lallemant M, Fineberg HV, Weinstein MC. Whose blood is safer? The effect of the stage of the epidemic on screening for HIV. Med Decis Making. 1997 Oct-Dec; 17(4):455-63. PMID: 9343804.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  86. Lallemant M, Le Coeur S, McIntosh K, Brennan T, Gelber R, Lee TH, Hammer S, Essex M, Vithayasai V, Sirivatanapa P, et al. AZT trial in Thailand. Science. 1995 Nov 10; 270(5238):899-900. PMID: 7481781.
    Citations: 1     Fields:    Translation:Humans
  87. Lallemant M, Le Coeur S. [Clinical experimentation with HIV vaccines: scientific and ethical dilemmas]. Hist Philos Life Sci. 1995; 17(1):151-69. PMID: 8552748.
    Citations:    Fields:    Translation:HumansCells
  88. Lallemant M, Le Coeur S, Samba L, Cheynier D, M'Pelé P, Nzingoula S, Essex M. Mother-to-child transmission of HIV-1 in Congo, central Africa. Congolese Research Group on Mother-to-Child Transmission of HIV. AIDS. 1994 Oct; 8(10):1451-6. PMID: 7818816.
    Citations: 5     Fields:    Translation:HumansCells
  89. Lallemant M, Baillou A, Lallemant-Le Coeur S, Nzingoula S, Mampaka M, M'Pelé P, Barin F, Essex M. Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women. Lancet. 1994 Apr 23; 343(8904):1001-5. PMID: 7909048.
    Citations: 6     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Lallemant's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (260)
Explore
_
Co-Authors (15)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.